IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v120y2016i5p519-534.html
   My bibliography  Save this article

Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts

Author

Listed:
  • Hu, Jia
  • Mossialos, Elias

Abstract

In recent years, there has been rapid growth in pharmaceutical spending in China. In addition, the country faces many challenges with regards to the quality, pricing and affordability of drugs. Pricing and reimbursement are important aspects of pharmaceutical policy that must be prioritised in order to address the many challenges.

Suggested Citation

  • Hu, Jia & Mossialos, Elias, 2016. "Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts," Health Policy, Elsevier, vol. 120(5), pages 519-534.
    • Handle: RePEc:eee:hepoli:v:120:y:2016:i:5:p:519-534
    DOI: 10.1016/j.healthpol.2016.03.014
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168851016300768
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.healthpol.2016.03.014?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zhang, Anwen & Nikoloski, Zlatko & Mossialos, Elias, 2017. "Does health insurance reduce out-of-pocket expenditure? Heterogeneity among China's middle-aged and elderly," Social Science & Medicine, Elsevier, vol. 190(C), pages 11-19.
    2. Yan Song & Ying Bian & Tianmin Zhen, 2018. "Making medicines more accessible in China: An empirical study investigating the early progress of essential medicine system," PLOS ONE, Public Library of Science, vol. 13(8), pages 1-13, August.
    3. Shu Yan & Lizi Pan & Yan Lu & Juan Chen & Ting Zhang & Dongzi Xu & Zhaolian Ouyang, 2023. "Towards Sustainable Drug Supply in China: A Bibliometric Analysis of Drug Reform Policies," Sustainability, MDPI, vol. 15(13), pages 1-20, June.
    4. Shi, Wunan & Wouters, Olivier J. & Liu, Gordon & Mossialos, Elias & Yang, Xiuyun, 2020. "Association between provincial income levels and drug prices in China over the period 2010–2017," Social Science & Medicine, Elsevier, vol. 263(C).
    5. Zhibek Omarkhanova & Danagul Tleuzhanova & Aigul Zholmukhanova & Zamira Mukhambetova & Sholpan Alpeissova, 2020. "Comparative analysis of social and economic efficiency in managing product innovations in the pharmaceutic industry," Entrepreneurship and Sustainability Issues, VsI Entrepreneurship and Sustainability Center, vol. 8(2), pages 1245-1266, December.
    6. Chen, Xu & Yang, Huan & Wang, Xiaojun, 2019. "Effects of price cap regulation on the pharmaceutical supply chain," Journal of Business Research, Elsevier, vol. 97(C), pages 281-290.
    7. Yuqing Tang & Chaojie Liu & Junjie Liu & Xinping Zhang & Keyuan Zuo, 2018. "Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, China," PharmacoEconomics, Springer, vol. 36(8), pages 995-1004, August.
    8. Yu Xia & Jing Li & Zhongyang Zhang, 2023. "Effects of price cap regulation on pharmaceutical supply chain under the zero markup drug policy," Operational Research, Springer, vol. 23(4), pages 1-27, December.
    9. Jiajing Li & Yanran Huang & Stephen Nicholas & Jian Wang, 2019. "China’s New Cooperative Medical Scheme’s Impact on the Medical Expenses of Elderly Rural Migrants," IJERPH, MDPI, vol. 16(24), pages 1-11, December.
    10. Yao, Ying & Tanaka, Makoto, 2020. "Price-quality trade-off in procurement auctions with an uncertain quality threshold," Journal of Economic Behavior & Organization, Elsevier, vol. 177(C), pages 56-70.
    11. Jiannan Li & Bocong Yuan, 2019. "Rural‐urban disparity in risk exposure to involuntary social health insurance transition in China: An investigation of chronic disease patients' mental health problems," International Journal of Health Planning and Management, Wiley Blackwell, vol. 34(4), pages 1760-1773, October.
    12. Kanavos, Panos & Mills, Mackenzie & Zhang, Anwen, 2019. "Pharmaceutical policy in China," LSE Research Online Documents on Economics 108473, London School of Economics and Political Science, LSE Library.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:120:y:2016:i:5:p:519-534. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.